Sonya Eremenco

Patient-centered drug development expert Sonya Eremenco and clinical research specialist John Powers discuss the importance of putting patients at the heart of COA approaches in clinical research, from concept to endpoint positioning. They explore the significance of aligning COA strategy with patient priorities, measuring disease attributes, and consulting patients early to determine key measures for improved participation and relevant metrics.